Target Name: ZNF367
NCBI ID: G195828
Review Report on ZNF367 Target / Biomarker Content of Review Report on ZNF367 Target / Biomarker
ZNF367
Other Name(s): CDC14 cell division cycle 14 homolog B | C2H2 zinc finger protein ZFF29a | C2H2 zinc finger protein ZFF29 | ZFF29 | zinc finger protein 367 | ZN367_HUMAN | AFF29 | CDC14B | Zinc finger protein 367

ZNF367: A Potential Drug Target and Biomarker for Parkinson's Disease

Parkinson's disease is a neurodegenerative disorder characterized by the degeneration of dopamine-producing neurons in the brain. It is a common cause of movement disorders, including tremors, rigidity, and bradykinesia. While there is currently no cure for Parkinson's disease, the development of new treatments and drug targets has the potential to slow the progression of the disease and improve quality of life for patients. ZNF367, a gene that has been identified as a potential drug target and biomarker for Parkinson's disease, is the focus of this article.

The ZNF367 gene

ZNF367 is a gene located on chromosome 12q34. It encodes for a protein known as ZNF367, which is a transcription factor that plays a role in regulating gene expression. ZNF367 is expressed in many tissues and cells in the body, including brain, heart, and muscle.

Parkinson's disease is associated with the degeneration of dopamine-producing neurons in the brain. The neurodegeneration that occurs in Parkinson's disease is thought to be caused by a combination of genetic and environmental factors. One of the genetic factors that has been identified as a risk factor for Parkinson's disease is the presence of genetic variants in the ZNF367 gene.

The ZNF367 gene and Parkinson's disease

Studies have shown that individuals with certain genetic variants, such as those found in the ZNF367 gene, are at an increased risk of developing Parkinson's disease. This suggests that ZNF367 may be a promising target for new treatments for Parkinson's disease.

In addition to its potential as a drug target, ZNF367 has also been identified as a potential biomarker for Parkinson's disease. The ZNF367 protein has been shown to be expressed in the brains of individuals with Parkinson's disease, and levels of ZNF367 have been shown to be decreased in the brains of individuals with the disease. These findings suggest that ZNF367 may be a useful biomarker for the diagnosis and monitoring of Parkinson's disease.

The potential uses of ZNF367 as a drug target and biomarker

The identification of ZNF367 as a potential drug target for Parkinson's disease has significant implications for the development of new treatments for the disease. If ZNF367 is indeed a reliable drug target, new treatments may be developed that specifically target this protein and reduce the production of dopamine-producing neurons in the brain.

In addition to its potential as a drug target, ZNF367 has also been identified as a potential biomarker for Parkinson's disease. The ZNF367 protein has been shown to be expressed in the brains of individuals with Parkinson's disease, and levels of ZNF367 have been shown to be decreased in the brains of individuals with the disease. These findings suggest that ZNF367 may be a useful biomarker for the diagnosis and monitoring of Parkinson's disease.

The potential uses of ZNF367 as a drug target and biomarker are vast and continue to be explored by researchers. Further studies are needed to determine the exact role of ZNF367 in the development and progression of Parkinson's disease, as well as the effectiveness of new treatments that target this protein.

Conclusion

ZNF367 is a gene that has been identified as a potential drug target and biomarker for Parkinson's disease. The identification of ZNF367 as a potential drug target has significant implications for the development of new treatments for the disease. Further research is needed to determine the exact role of ZNF367 in the

Protein Name: Zinc Finger Protein 367

Functions: Transcriptional activator. Isoform 1 may be involved in transcriptional activation of erythroid genes

The "ZNF367 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF367 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF37A | ZNF37BP | ZNF382 | ZNF383 | ZNF384 | ZNF385A | ZNF385B | ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415 | ZNF416 | ZNF417 | ZNF418 | ZNF419 | ZNF420 | ZNF423 | ZNF425 | ZNF426 | ZNF428 | ZNF429 | ZNF43 | ZNF430 | ZNF431 | ZNF432 | ZNF433 | ZNF433-AS1 | ZNF436 | ZNF436-AS1 | ZNF438 | ZNF439 | ZNF44 | ZNF440 | ZNF441 | ZNF442 | ZNF443 | ZNF444 | ZNF445 | ZNF446 | ZNF449 | ZNF45 | ZNF451 | ZNF454 | ZNF460 | ZNF461 | ZNF462 | ZNF467 | ZNF468 | ZNF469 | ZNF470 | ZNF471 | ZNF473 | ZNF473CR | ZNF479 | ZNF48 | ZNF480 | ZNF483 | ZNF484 | ZNF485 | ZNF486 | ZNF487 | ZNF488 | ZNF490 | ZNF491 | ZNF492 | ZNF493 | ZNF496 | ZNF497 | ZNF497-AS1 | ZNF500 | ZNF501 | ZNF502 | ZNF503 | ZNF503-AS1 | ZNF503-AS2 | ZNF506 | ZNF507 | ZNF510 | ZNF511 | ZNF512 | ZNF512B | ZNF513 | ZNF514 | ZNF516 | ZNF516-DT